jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Protein Creatinine Ratio (PCR) - Spot Sample

Kidney
image

Report in 4Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Evaluates protein loss in urine normalized to creatinine; used in diagnosing and monitoring kidney disease.

249950

74% OFF

Protein Creatinine Ratio (PCR) - Spot Sample

  • Why is it done?
    • Measures the amount of protein in a single urine sample relative to creatinine concentration to detect and quantify proteinuria (protein in urine)
    • Screening and diagnosis of kidney disease, particularly in patients with diabetes, hypertension, or systemic disease
    • Monitoring kidney function in patients with known chronic kidney disease (CKD) or diabetic nephropathy
    • Assessment of proteinuria progression and response to treatment
    • Evaluation of patients with persistent microscopic or macroscopic hematuria
    • Preferred screening test during pregnancy to detect preeclampsia or gestational proteinuria
    • Typically performed during routine physical examinations or when kidney disease is suspected
  • Normal Range
    • Reference Range: Less than 30 mg/mmol creatinine (or <30 mg/g creatinine)
    • Units of Measurement: mg/mmol creatinine (SI units) or mg/g creatinine (conventional units)
    • Albumin-to-Creatinine Ratio (ACR) - Alternative: Less than 2.5 mg/mmol for men; less than 3.5 mg/mmol for women
    • Normal Result: PCR <30 mg/mmol indicates normal kidney function with absent or minimal proteinuria, suggesting no significant protein loss in urine
    • Abnormal Result: PCR ≥30 mg/mmol indicates proteinuria and suggests kidney dysfunction, disease process, or other medical conditions requiring further investigation
  • Interpretation
    • PCR <30 mg/mmol (Normal/Negative): Indicates normal protein excretion and generally healthy kidney function; absence of clinically significant proteinuria
    • PCR 30-300 mg/mmol (Microalbuminuria/Mild Proteinuria): Suggests early kidney disease or early-stage diabetic nephropathy; requires follow-up testing and medical intervention to prevent progression
    • PCR >300 mg/mmol (Macroalbuminuria/Significant Proteinuria): Indicates substantial kidney damage, moderate to advanced chronic kidney disease, or active kidney disease requiring urgent medical attention and management
    • Factors Affecting Results: Acute infection or fever, intense exercise, dehydration, menstrual cycle, pregnancy, hypertension, medications, urinary tract infection, or recent illness may temporarily elevate PCR; repeat testing recommended after resolution of acute conditions
    • Clinical Significance: PCR is a sensitive marker of glomerular filtration barrier dysfunction; persistent proteinuria indicates progressive kidney disease requiring treatment with ACE inhibitors or ARBs to slow disease progression and prevent kidney failure
    • Serial Measurements: Multiple measurements over time are more clinically meaningful than single measurements to establish disease trajectory and treatment response
  • Associated Organs
    • Primary Organ System: Kidneys and urinary system; specifically the glomeruli (filtering units of the kidney)
    • Common Conditions Associated with Abnormal Results:
    • Type 1 and Type 2 diabetes mellitus with diabetic nephropathy
    • Hypertension and hypertensive nephrosclerosis
    • Glomerulonephritis (various types including IgA nephropathy, membranous nephropathy, lupus nephritis)
    • Chronic kidney disease (CKD) stages 1-5
    • Systemic lupus erythematosus (SLE) and other autoimmune diseases
    • Polycystic kidney disease
    • Preeclampsia and eclampsia during pregnancy
    • Vasculitis syndromes affecting kidney vasculature
    • Amyloidosis affecting kidney tissue
    • Potential Complications of Abnormal Results:
    • Progressive decline in glomerular filtration rate (GFR) leading to acute or chronic kidney failure
    • End-stage renal disease (ESRD) requiring dialysis or transplantation
    • Cardiovascular complications including hypertension, myocardial infarction, and stroke
    • Fluid and electrolyte imbalances
    • Anemia and bone disease (renal osteodystrophy)
  • Follow-up Tests
    • Recommended Follow-up Testing if PCR is Abnormal:
    • Serum creatinine and estimated glomerular filtration rate (eGFR) to assess overall kidney function
    • Blood urea nitrogen (BUN) to evaluate kidney function and protein metabolism
    • 24-hour urine protein collection for comprehensive proteinuria quantification and validation
    • Albumin-to-creatinine ratio (ACR) as alternative or confirmatory test for proteinuria
    • Complete metabolic panel (electrolytes, glucose, calcium, phosphorus) to assess overall metabolic status
    • Hemoglobin A1C in diabetic patients to assess glycemic control
    • Blood pressure monitoring and lipid profile to assess cardiovascular risk
    • Urinalysis to examine for hematuria, casts, and other abnormalities
    • Renal ultrasound or kidney imaging if kidney disease is suspected or confirmed
    • Immunological testing (ANA, complement levels) if autoimmune disease is suspected
    • Kidney biopsy if diagnosis remains unclear or rapid progression is observed
    • Monitoring Frequency:
    • Initial normal result: Repeat annually or per clinical guidelines for at-risk populations
    • Microalbuminuria detected: Repeat testing within 3-6 months; confirm with repeat measurements
    • Significant proteinuria detected: Repeat testing at 1-3 month intervals during initial diagnostic phase
    • Established kidney disease: Monitor every 3-6 months depending on disease stage and treatment response
  • Fasting Required?
    • Fasting Requirement: No
    • Specimen Collection: A random (spot) urine sample can be collected at any time of day; first morning urine is preferred and most commonly used due to more concentrated creatinine levels
    • Patient Preparation Instructions:
    • No special fasting requirements; patient may eat and drink normally before specimen collection
    • Patient should maintain normal hydration status; extreme dehydration or excessive fluid intake may affect urine concentration and results
    • Avoid strenuous exercise or intense physical activity for 24 hours before specimen collection as this may transiently increase protein excretion
    • For women: Avoid testing during menstruation as this may contaminate the specimen and cause false results
    • Use of clean-catch midstream collection technique to minimize bacterial contamination and prevent false positive results
    • Medications to Continue:
    • Continue all regular medications as prescribed unless otherwise instructed by physician; no medications need to be withheld for specimen collection
    • Specimen Handling:
    • Collect at least 30-50 mL of urine in a clean, sterile container provided by the laboratory
    • Do not refrigerate specimen; deliver to laboratory within 2 hours of collection at room temperature
    • Label specimen container clearly with patient identification, date, and time of collection

How our test process works!

customers
customers